Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (701-710 of 839) with videos related to

Pageof 84
Sort By:
European Urology|November 28, 2016
Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Marshall D Brown, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Oncogene|April 23, 2013
The role of DAB2IP in androgen receptor activation during prostate cancer progressionK Wu, J Liu, S-F Tseng, et al.
Plos One|July 15, 2015
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 PatientsJames D Brooks, Wei Wei, Sarah Hawley, et al.
Plos Pathogens|August 13, 2013
Genomic analysis of the Kiwifruit pathogen Pseudomonas syringae pv. actinidiae provides insight into the origins of an emergent plant diseaseHonour C McCann, Erik H A Rikkerink, Frederic Bertels, et al.
The Journal of Urology|December 9, 2025
Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary Endpoints From the EMBARK TrialNeal D Shore, Martin Gleave, Ugo De Giorgi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2025
Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Journal of the National Cancer Institute|December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate CancerAlexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway InhibitionMatti Annala, Sinja Taavitsainen, Daniel J Khalaf, et al.
Plos One|November 16, 2016
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional StudyOkyaz Eminaga, Wei Wei, Sarah J Hawley, et al.
Pageof 84

Showing results (701-710 of 839) with videos related to

Sort By:
Pageof 84
European Urology|November 28, 2016
Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Marshall D Brown, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Oncogene|April 23, 2013
The role of DAB2IP in androgen receptor activation during prostate cancer progressionK Wu, J Liu, S-F Tseng, et al.
Plos One|July 15, 2015
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 PatientsJames D Brooks, Wei Wei, Sarah Hawley, et al.
Plos Pathogens|August 13, 2013
Genomic analysis of the Kiwifruit pathogen Pseudomonas syringae pv. actinidiae provides insight into the origins of an emergent plant diseaseHonour C McCann, Erik H A Rikkerink, Frederic Bertels, et al.
The Journal of Urology|December 9, 2025
Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary Endpoints From the EMBARK TrialNeal D Shore, Martin Gleave, Ugo De Giorgi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2025
Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Journal of the National Cancer Institute|December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate CancerAlexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway InhibitionMatti Annala, Sinja Taavitsainen, Daniel J Khalaf, et al.
Plos One|November 16, 2016
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional StudyOkyaz Eminaga, Wei Wei, Sarah J Hawley, et al.
Pageof 84